Erectile dysfunction after radical prostatectomy : patient information, contact persons, postoperative proerectile therapy

• Published in: Urologe. Ausgabe A 2010-04, Vol.49 (4), p.525
• Main Authors: Kaufmann, S, Al-Najar, A, Boy, S, Hamann, M F, Naumann, C M, Fritzer, E, Jünemann, K P, van der Horst, C
• Format: Article
• Language: ger
• Subjects: Aged; Cooperative Behavior; Drug Costs; Erectile Dysfunction - drug therapy; Erectile Dysfunction - economics; Erectile Dysfunction - etiology; Financing, Personal; Germany; Humans; Interdisciplinary Communication; Male; Middle Aged; Patient Acceptance of Health Care; Patient Care Team; Patient Education as Topic; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors - adverse effects; Phosphodiesterase Inhibitors - economics; Phosphodiesterase Inhibitors - therapeutic use; Postoperative Complications - drug therapy; Postoperative Complications - etiology; Prostatectomy; Prostatic Neoplasms - surgery; Surveys and Questionnaires
• ISSN: 1433-0563
• DOI: 10.1007/s00120-009-2190-2

Postoperative erectile dysfunction (ED) is one of the potential after-effects of radical prostatectomy. The aim of this study was to learn which caregivers inform the patients prior to the intervention about the risk of ED, which individuals the patients discuss this issue with, and whether the patients preoperatively consider use of a PDE5 inhibitor for proerectile therapy after the operation. Using the IIEF-5 questionnaire, the preoperative erectile function of 110 patients was evaluated after the hospital admission interview. The patients were asked who had informed them about the risk of postoperative ED. They were also asked in whom they had confided to discuss this issue and whether they were prepared to undergo postoperative proerectile therapy with a PDE5 inhibitor. The patients were subsequently assigned to one of two groups: group I, consisting of those with a preoperative IIEF score > or = 21, or group II, those with a preoperative IIEF score